FDAs Regulatory Modernization: Missed Opportunity or the Future of Pharma? PART 1
United States FDA Introduces a New Initiative Readers may be familiar with the words of FDAs Janet Woodcock, MD, in the early 2000s, calling for:
United States FDA Introduces a New Initiative Readers may be familiar with the words of FDAs Janet Woodcock, MD, in the early 2000s, calling for:
In Part 1, we concluded that 21st Century cGMP faces critical challenges, given four-decades of strategic realignment of industry business models. Readers wishing to recap
What is cGMP for the 21st Century? As many reading this will know, cGMP, stands for current Good Manufacturing Practice. It is the quality management
What is medicinal product (drug) repurposing? Repurposing a medicinal product (drug or biologic) involves gaining a licence for an already approved, non-patented product, in different
Bridgend, South Wales, 7th June 2022: PharmaFlow, a 21st century consultancy in biopharmaceutical value-chains, is pleased to announce that founder and managing director, Hedley Rees,
Bridgend, South Wales, 29th March 2021: Following the chaos and confusion during COVID-19, Hedley Rees has decided to share his deep experience of pharmaceutical production